$0.487
-0.068 (-13.96%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Neumora Therapeutics Inc (NMRA) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting NMRA is Sell.
Neumora Therapeutics Inc (NMRA) 20-Day simple moving average is 0.43, while Neumora Therapeutics Inc (NMRA) share price is $—, making it Buy.
Neumora Therapeutics Inc (NMRA) 60-Day simple moving average is 0.86, while Neumora Therapeutics Inc (NMRA) share price is $—, making it Sell.
Technical Analysis for NMRA
AI Technical NMRAAs of 2026-11-03, the technical board for Neumora Therapeutics Inc (NMRA) reads sell: 3 indicators are flashing buy, 6 are indicating sell, and 4 are neutral. Price at $0.49 sits below the 5-day, 60-day and 200-day moving averages and above the 10-day and 20-day.
Momentum readings: RSI stands at 46.025, MACD stands at -0.0539 (Sell), Stochastic %K stands at 65.814, Stochastic %D stands at 70.381 and CCI stands at 86.142.
NMRA trades below the 60-day SMA (0.86) and below the 200-day SMA (1.75). Immediate resistance sits at Classic R1 0.61, then R2 0.78. Support sits at Classic S1 0.31, then S2 0.18.
Neumora Therapeutics Inc (NMRA) Support & Resistance Level
Neumora Therapeutics Inc (NMRA) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 46.025 |
| STOCHk_14_3_3 | 65.814 |
| STOCHd_14_3_3 | 70.381 |
| CCI_20 | 86.142 |
| AO_5_34 | -0.018 |
| MOM_10 | 0.081 |
| MACD_12_26_9 | -0.054 |
Neumora Therapeutics Inc (NMRA) Relative Strength Index (RSI_14) is 46.025, creating a Neutral signal.
Neumora Therapeutics Inc (NMRA) Stochastic %K is 65.814, creating a Neutral signal.
Neumora Therapeutics Inc (NMRA) Stochastic %D is 70.381, creating a Neutral signal.
Neumora Therapeutics Inc (NMRA) CCI_20 is 86.142, creating a Neutral signal.
Neumora Therapeutics Inc (NMRA) Awesome Oscillator (AO) is -0.018, creating a Sell signal.
Neumora Therapeutics Inc (NMRA) Momentum (MOM) is 0.081, creating a Buy signal.
Neumora Therapeutics Inc (NMRA) Moving Average Convergence Divergence (MACD) is -0.054, creating a Sell signal.
Neumora Therapeutics Inc (NMRA) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.497 | Sell |
| MA_10 | 0.441 | Buy |
| MA_20 | 0.435 | Buy |
| MA_60 | 0.856 | Sell |
| MA_200 | 1.750 | Sell |
| MA_250 | 1.830 | Sell |
Neumora Therapeutics Inc (NMRA) 5-Day simple moving average is 0.497, while Neumora Therapeutics Inc (NMRA) share price is $, making it a Sell.
Neumora Therapeutics Inc (NMRA) 10-Day simple moving average is 0.441, while Neumora Therapeutics Inc (NMRA) share price is $, making it a Buy.
Neumora Therapeutics Inc (NMRA) 20-Day simple moving average is 0.435, while Neumora Therapeutics Inc (NMRA) share price is $, making it a Buy.
Neumora Therapeutics Inc (NMRA) 60-Day simple moving average is 0.856, while Neumora Therapeutics Inc (NMRA) share price is $, making it a Sell.
Neumora Therapeutics Inc (NMRA) 200-Day simple moving average is 1.750, while Neumora Therapeutics Inc (NMRA) share price is $, making it a Sell.
Neumora Therapeutics Inc (NMRA) 250-Day simple moving average is 1.830, while Neumora Therapeutics Inc (NMRA) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.